Bayer AG (Leverkusen, Germany) announced the grand opening of its new 70,000 square foot expansion at its Myerstown, ...

The expansion strengthens Bayer’s ability to deliver health-focused products more efficiently across North America.

Bayer is boosting its precision oncology efforts with a molecular database from health tech firm ConcertAI.  | Bayer is ...

Bayer is expanding its Lebanon County facility by adding 70,000 square feet of production space and incorporating new ...

A new publication in the British Medical Journal reviewed current clinical data and found NSAIDs like Aleve and Bayer Aspirin ...

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...

It's worth noting that Bayer has its own PSMA-targeting thorium-227 drug – BAY 2315497 – in phase 1 development, which uses an antibody for tumour targeting.

Two prominent German investors voiced exasperation over Bayer AG’s recurring struggles, demanding a clearer path out of the ...